Entero Healthcare Solutions
Entero Healthcare delivered a strong Q3 FY26 with revenue of ₹1,771 crore (+26% YoY) and EBITDA of ₹68 crore (+36% YoY), driven by organic growth of 17.1% and contributions from recent medtech acquisitions.
Entero Healthcare Solutions vs Eris Lifesciences Q3 FY26
Side-by-side earnings comparison across verified financials, sentiment, risks, and management commentary.
Eris Lifesciences
Eris Lifesciences reported Q1 FY26 consolidated revenue of ₹773 crore (+7.4% YoY) and PAT of ₹125 crore (+41% YoY), driven by strong domestic branded business (DBS) growth of 11% and margin expansion.
Result Snapshot
Revenue₹1,707 Cr₹807 Cr
PAT₹34 Cr₹109 Cr
EBITDA Margin4%35%
Sentimentbullishbullish
Key Quotes
We are on track to deliver our full year guidance.
We retain our position that we expect to be among the first launches in India post LOE.